144 related articles for article (PubMed ID: 12220491)
21. Three-dimensional modeling of and ligand docking to vitamin D receptor ligand binding domain.
Yamamoto K; Masuno H; Choi M; Nakashima K; Taga T; Ooizumi H; Umesono K; Sicinska W; VanHooke J; DeLuca HF; Yamada S
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1467-72. PubMed ID: 10677485
[TBL] [Abstract][Full Text] [Related]
22. Artificial protein cavities as specific ligand-binding templates: characterization of an engineered heterocyclic cation-binding site that preserves the evolved specificity of the parent protein.
Musah RA; Jensen GM; Bunte SW; Rosenfeld RJ; Goodin DB
J Mol Biol; 2002 Jan; 315(4):845-57. PubMed ID: 11812152
[TBL] [Abstract][Full Text] [Related]
23. Serine 232 and methionine 272 define the ligand binding pocket in retinoic acid receptor subtypes.
Ostrowski J; Roalsvig T; Hammer L; Marinier A; Starrett JE; Yu KL; Reczek PR
J Biol Chem; 1998 Feb; 273(6):3490-5. PubMed ID: 9452473
[TBL] [Abstract][Full Text] [Related]
24. An Unexpected Mode Of Binding Defines BMS948 as A Full Retinoic Acid Receptor β (RARβ, NR1B2) Selective Agonist.
Nadendla E; Teyssier C; Delfosse V; Vivat V; Krishnasamy G; Gronemeyer H; Bourguet W; Germain P
PLoS One; 2015; 10(5):e0123195. PubMed ID: 25933005
[TBL] [Abstract][Full Text] [Related]
25. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
Bhunia SS; Roy KK; Saxena AK
J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.
Renaud JP; Rochel N; Ruff M; Vivat V; Chambon P; Gronemeyer H; Moras D
Nature; 1995 Dec; 378(6558):681-9. PubMed ID: 7501014
[TBL] [Abstract][Full Text] [Related]
27. C-X...H contacts in biomolecular systems: how they contribute to protein-ligand binding affinity.
Lu Y; Wang Y; Xu Z; Yan X; Luo X; Jiang H; Zhu W
J Phys Chem B; 2009 Sep; 113(37):12615-21. PubMed ID: 19708644
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of C-H cdots, three dots, centered O hydrogen bonds in native and misfolded proteins.
Chamberlain AK; Bowie JU
J Mol Biol; 2002 Sep; 322(3):497-503. PubMed ID: 12225744
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
[TBL] [Abstract][Full Text] [Related]
30. Neutron Crystallography for the Study of Hydrogen Bonds in Macromolecules.
Oksanen E; Chen JC; Fisher SZ
Molecules; 2017 Apr; 22(4):. PubMed ID: 28387738
[No Abstract] [Full Text] [Related]
31. Role of Ser(289) in RARgamma and its homologous amino acid residue of RARalpha and RARbeta in the binding of retinoic acid.
Zhang ZP; Shukri M; Gambone CJ; Gabriel JL; Soprano KJ; Soprano DR
Arch Biochem Biophys; 2000 Aug; 380(2):339-46. PubMed ID: 10933889
[TBL] [Abstract][Full Text] [Related]
32. Binding of genistein to the estrogen receptor based on an experimental electron density study.
Yearley EJ; Zhurova EA; Zhurov VV; Pinkerton AA
J Am Chem Soc; 2007 Dec; 129(48):15013-21. PubMed ID: 17994745
[TBL] [Abstract][Full Text] [Related]
33. Density functional and docking studies of retinoids for cancer treatment.
Silva CH; Almeida P; Taft CA
J Mol Model; 2004 Feb; 10(1):38-43. PubMed ID: 14634847
[TBL] [Abstract][Full Text] [Related]
34. Nonbonding interactions of organic halogens in biological systems: implications for drug discovery and biomolecular design.
Lu Y; Wang Y; Zhu W
Phys Chem Chem Phys; 2010 May; 12(18):4543-51. PubMed ID: 20428531
[TBL] [Abstract][Full Text] [Related]
35. Three-dimensional models of estrogen receptor ligand binding domain complexes, based on related crystal structures and mutational and structure-activity relationship data.
Wurtz JM; Egner U; Heinrich N; Moras D; Mueller-Fahrnow A
J Med Chem; 1998 May; 41(11):1803-14. PubMed ID: 9599231
[TBL] [Abstract][Full Text] [Related]
36. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
37. Definition and display of steric, hydrophobic, and hydrogen-bonding properties of ligand binding sites in proteins using Lee and Richards accessible surface: validation of a high-resolution graphical tool for drug design.
Bohacek RS; McMartin C
J Med Chem; 1992 May; 35(10):1671-84. PubMed ID: 1588550
[TBL] [Abstract][Full Text] [Related]
38. Hydrogen bonds as structural directive towards unusual polynuclear complexes: synthesis, structure, and magnetic properties of copper(II) and nickel(II) complexes with a 2-aminoglucose ligand.
Burkhardt A; Spielberg ET; Simon S; Görls H; Buchholz A; Plass W
Chemistry; 2009; 15(5):1261-71. PubMed ID: 19101969
[TBL] [Abstract][Full Text] [Related]
39. A role for CH...O interactions in protein-DNA recognition.
Mandel-Gutfreund Y; Margalit H; Jernigan RL; Zhurkin VB
J Mol Biol; 1998 Apr; 277(5):1129-40. PubMed ID: 9571027
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of apo-cellular retinoic acid-binding protein type II (R111M) suggests a mechanism of ligand entry.
Chen X; Tordova M; Gilliland GL; Wang L; Li Y; Yan H; Ji X
J Mol Biol; 1998 May; 278(3):641-53. PubMed ID: 9600845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
